Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | KDM1A | O60341 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27174942 | 1.00 | L3MBTL1 (0.32) | L3MBTL1DGAT1LMNAHTTSMN1; SMN2 | |
| SCHEMBL27174910 | 0.81 | MAPT (0.31) | TDP1POLB | |
| SCHEMBL31482767 | 0.81 | MAPT (0.31) | TDP1POLB | |
| SCHEMBL13961214 | 0.76 | DGAT1 (0.31) | DGAT1HTTSMN1; SMN2TDP1POLB | |
| SCHEMBL2423387 | 0.76 | DGAT1 (0.33) | DGAT1HTTSMN1; SMN2TDP1POLB | |
| SCHEMBL22803875 | 0.75 | POLB (0.37) | L3MBTL1LMNAHTTSMN1; SMN2TDP1 | |
| SCHEMBL5253803 | 0.74 | NPC1 (0.34) | KDM1A | |
| SCHEMBL2431756 | 0.73 | KDM4E (0.33) | — | |
| SCHEMBL2432945 | 0.73 | KDM4E (0.32) | POLB | |
| SCHEMBL30799248 | 0.73 | DGAT1 (0.37) | DGAT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4573088-A1 | HETEROCYCLE RBM39 MODULATORS | Recursion Pharmaceuticals, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| CN-119630658-A | Heterocyclic RBM39 modulators | 递归医药公司 | 2025-03-14 | — | — | CN | disclosed |
| WO-2024039689-A1 | HETEROCYCLE RBM39 MODULATORS | RECURSION PHARMACEUTICALS, INC. (US) | 2024-02-22 | — | — | WO | disclosed |